Ohr Pharmaceutical Reports Third Quarter 2016 Financial and Business Results
NEW YORK, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today reported results for its third quarter ended June 30, 2016. “The start of the Phase 3 registration program for …